Radiosurgery in the treatment of malignant melanoma
Alberta Heritage Foundation for Medical Research
Record ID 31998008927
Authors' objectives: This report has been prepared in response to a request for advice in respect of treatment of an individual with a history of malignant melanoma.
Authors' recomendations: There is evidence that stereotactic radiosurgery (both gamma knife and linac) is helpful in the management of brain metastases, often in association with other forms of treatment. Benefits include local control in a high proportion of cases, and improvement of clinical symptoms. Effects on survival seem less clear, with limited comparative data in cases where surgery is a treatment option. Patient selection criteria require further development, and the role of radiosurgery in any individual case will be a matter for careful judgment by the specialists providing treatment. From the information available for preparation of this note, the evidence of benefit from treatment of cerebral metastatic melanoma with radiosurgery is less clear, though there are again indications of achievement of good local control and improved clinical symptoms in a condition with very poor prognosis. The technology is now being used at a number of centres in the management of metastatic melanoma cases, though its role and outcomes require further validation.
Authors' methods: Review
Project Status: Completed
Year Published: 1997
URL for published report: https://www.ihe.ca/advanced-search?type=1020
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Neoplasm Metastasis
- Stereotaxic Techniques
Organisation Name: Institute of Health Economics
Contact Address: 1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada, T5J 3N4. Tel: +1 780 448 4881; Fax: +1 780 448 0018;
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: Alberta Heritage Foundation for Medical Research
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.